Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst

For years, top pharma companies responded to pricing criticism by pledging to limit their increases. After Allergan CEO Brent Saunders proposed keeping annual price hikes under 10% amid sharp drug pricing scrutiny, many companies followed suit.